Wells Fargo’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$398M Buy
3,708,088
+149,530
+4% +$16.1M 0.08% 206
2025
Q1
$359M Buy
3,558,558
+366,749
+11% +$37M 0.08% 214
2024
Q4
$285M Buy
3,191,809
+83,431
+3% +$7.45M 0.06% 243
2024
Q3
$260M Sell
3,108,378
-47,109
-1% -$3.95M 0.06% 253
2024
Q2
$243M Sell
3,155,487
-38,217
-1% -$2.94M 0.06% 260
2024
Q1
$219M Buy
3,193,704
+396,799
+14% +$27.2M 0.05% 277
2023
Q4
$162M Sell
2,796,905
-155,845
-5% -$9.01M 0.04% 322
2023
Q3
$156M Sell
2,952,750
-430,998
-13% -$22.8M 0.05% 304
2023
Q2
$183M Sell
3,383,748
-136,719
-4% -$7.4M 0.05% 285
2023
Q1
$176M Sell
3,520,467
-193,368
-5% -$9.67M 0.05% 291
2022
Q4
$172M Sell
3,713,835
-32,856
-0.9% -$1.52M 0.05% 297
2022
Q3
$145M Sell
3,746,691
-2,470
-0.1% -$95.7K 0.05% 312
2022
Q2
$140M Sell
3,749,161
-835,614
-18% -$31.1M 0.04% 328
2022
Q1
$203M Buy
4,584,775
+669,036
+17% +$29.6M 0.05% 288
2021
Q4
$166M Sell
3,915,739
-3,944,533
-50% -$168M 0.04% 328
2021
Q3
$341M Buy
7,860,272
+348,398
+5% +$15.1M 0.07% 243
2021
Q2
$321M Buy
7,511,874
+451,146
+6% +$19.3M 0.07% 258
2021
Q1
$273M Sell
7,060,728
-1,588,179
-18% -$61.4M 0.06% 300
2020
Q4
$311M Sell
8,648,907
-2,494,701
-22% -$89.7M 0.07% 255
2020
Q3
$426M Sell
11,143,608
-204,107
-2% -$7.8M 0.12% 170
2020
Q2
$398M Sell
11,347,715
-1,193,032
-10% -$41.9M 0.12% 174
2020
Q1
$409M Buy
12,540,747
+1,646,596
+15% +$53.7M 0.14% 153
2019
Q4
$493M Sell
10,894,151
-317,188
-3% -$14.3M 0.13% 154
2019
Q3
$456M Buy
11,211,339
+304,891
+3% +$12.4M 0.13% 157
2019
Q2
$469M Sell
10,906,448
-65,001
-0.6% -$2.79M 0.13% 154
2019
Q1
$421M Buy
10,971,449
+66,983
+0.6% +$2.57M 0.13% 163
2018
Q4
$385M Sell
10,904,466
-116,830
-1% -$4.13M 0.13% 158
2018
Q3
$424M Sell
11,021,296
-796,346
-7% -$30.7M 0.12% 168
2018
Q2
$386M Sell
11,817,642
-912,854
-7% -$29.9M 0.11% 181
2018
Q1
$348M Buy
12,730,496
+784,825
+7% +$21.4M 0.1% 201
2017
Q4
$296M Buy
11,945,671
+2,705,194
+29% +$67.1M 0.09% 237
2017
Q3
$270M Buy
9,240,477
+82,709
+0.9% +$2.41M 0.08% 245
2017
Q2
$254M Buy
9,157,768
+867,983
+10% +$24.1M 0.08% 251
2017
Q1
$206M Buy
8,289,785
+200,190
+2% +$4.98M 0.07% 296
2016
Q4
$175M Buy
8,089,595
+1,273,355
+19% +$27.5M 0.06% 323
2016
Q3
$162M Buy
6,816,240
+550,336
+9% +$13.1M 0.06% 340
2016
Q2
$146M Buy
6,265,904
+138,162
+2% +$3.23M 0.06% 362
2016
Q1
$115M Buy
6,127,742
+2,825,011
+86% +$53.1M 0.05% 417
2015
Q4
$60.9M Buy
3,302,731
+260,006
+9% +$4.79M 0.02% 665
2015
Q3
$49.9M Buy
3,042,725
+346,140
+13% +$5.68M 0.02% 743
2015
Q2
$47.7M Buy
2,696,585
+863,307
+47% +$15.3M 0.02% 830
2015
Q1
$32.5M Buy
1,833,278
+26,345
+1% +$468K 0.01% 1031
2014
Q4
$23.9M Sell
1,806,933
-1,802,107
-50% -$23.9M 0.01% 1169
2014
Q3
$42.6M Sell
3,609,040
-340,274
-9% -$4.02M 0.02% 826
2014
Q2
$50.4M Sell
3,949,314
-14,045,198
-78% -$179M 0.02% 767
2014
Q1
$243M Sell
17,994,512
-2,082,199
-10% -$28.2M 0.1% 238
2013
Q4
$241M Buy
20,076,711
+8,927,050
+80% +$107M 0.1% 240
2013
Q3
$131M Buy
11,149,661
+7,721,043
+225% +$90.6M 0.06% 352
2013
Q2
$31.8M Buy
+3,428,618
New +$31.8M 0.02% 869